These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32299754)

  • 1. The Role of Breast Cancer Stem Cells and Some Related Molecular Biomarkers in Metastatic and Nonmetastatic Breast Cancer.
    El Abbass KA; Abdellateif MS; Gawish AM; Zekri AN; Malash I; Bahnassy AA
    Clin Breast Cancer; 2020 Aug; 20(4):e373-e384. PubMed ID: 32299754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nectin-4 is a breast cancer stem cell marker that induces WNT/β-catenin signaling via Pi3k/Akt axis.
    Siddharth S; Goutam K; Das S; Nayak A; Nayak D; Sethy C; Wyatt MD; Kundu CN
    Int J Biochem Cell Biol; 2017 Aug; 89():85-94. PubMed ID: 28600142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway.
    Tang W; Li M; Qi X; Li J
    Cancer Res Treat; 2020 Oct; 52(4):1084-1102. PubMed ID: 32599982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
    Li Y; Wu C
    IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN.
    Xiao S; Zhu H; Luo J; Wu Z; Xie M
    Oncol Rep; 2019 Dec; 42(6):2550-2560. PubMed ID: 31638259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.
    Chen D; Bhat-Nakshatri P; Goswami C; Badve S; Nakshatri H
    Cancer Res; 2013 Sep; 73(18):5821-33. PubMed ID: 23832666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome sequencing of HER2-positive breast cancer stem cells identifies potential prognostic marker.
    Lei B; Zhang XY; Zhou JP; Mu GN; Li YW; Zhang YX; Pang D
    Tumour Biol; 2016 Nov; 37(11):14757-14764. PubMed ID: 27629143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1-regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation.
    Liu X; Xie P; Hao N; Zhang M; Liu Y; Liu P; Semenza GL; He J; Zhang H
    Proc Natl Acad Sci U S A; 2021 Nov; 118(44):. PubMed ID: 34706936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
    Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
    Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of breast cancer axillary lymph node metastases with stem cell mutations.
    Donovan CA; Pommier RF; Schillace R; O'Neill S; Muller P; Alabran JL; Hansen JE; Murphy JA; Naik AM; Vetto JT; Pommier SJ
    JAMA Surg; 2013 Sep; 148(9):873-8. PubMed ID: 23884447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.
    Zhao Y; Wang Y; Zhu F; Zhang J; Ma X; Zhang D
    Clin Exp Med; 2020 May; 20(2):249-259. PubMed ID: 31980982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
    Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
    Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
    Rappa G; Lorico A
    Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.